Effectiveness of the Reitman Centre CARERS Group Intervention on Family Caregivers of Persons With Dementia

July 27, 2020 updated by: Joel Sadavoy, Mount Sinai Hospital, Canada

Family caregivers (CG) of persons with dementia are vulnerable to disproportionate physical, mental and social adverse health consequences . The Reitman Centre CARERS program is an innovative, group psychotherapeutic skills-training intervention.

Study objective: to determine the effectiveness of the Reitman Centre CARERS program on key outcomes in family CGs of people with dementia. Study sample: Family CGs of people with dementia (n=264) referred to Reitman Center and the partner sites and wait-list control group (n=83) who received regular care. Method: quasi-experimental, non-randomized, multiple group trial; participants were evaluated before and after completion of the 8-week CARERS program in comparison.

Study Overview

Status

Completed

Intervention / Treatment

Detailed Description

Addressing the adverse effects of caregiving on dementia CGs has been an increasing concern of mental and social health scholars in recent decades. Many single and multi-component programs have been developed but evidence for the effectiveness of interventions varies. Single component interventions for CGs like education, psychotherapy, or skills training are effective on various outcome measures but multicomponent programs appear to be preferred for overall reduction of caregiver burden. Broad development and system-wide adoption of interventions lags behind and there remains a need for evidence-based interventions that can be scaled widely in systems of dementia care.

This study aimed to compare the effectiveness of the Reitman Centre CARERS group intervention on measures of CG's health and well-being with a usual-care intervention control group. We hypothesized that the integrated, multicomponent CARERS program would produce robust positive effects on key outcome measures compared to waiting list controls. This was a quasi-experimental design with a convenience sample and a non-randomized wait-list control group implemented between 2013 and 2017. The control group received usual care before starting the CARERS intervention.The waiting list control group was derived from all CGs who were clinically assessed for the CARERS program, consented to enter the study and completed initial study assessments before being put on the waiting list for a CARERS group. A waiting list control was employed for practical recruitment purposes. This study was approved by the Sinai Health System (SHS) Research Ethics Board. Every participant provided informed signed written consent for all study components.Referrals to the study came from community agencies serving older adults, self-referrals, and primary care, memory, general psychiatry and geriatric medicine clinics. The intervention sites were located at Reitman Centre (CR) and Wellness Centre at Mount Sinai Hospital, Bridgepoint Active Health, Ceridian LifeWorks® EAP, Canadian Alzheimer Society chapters and community agencies serving older adults.

The intervention, called Carers, is a multicomponent, group psychotherapeutic, skills-training intervention for family CGs comprised of 8 weekly 2 hour closed groups sessions. of 4-6 CGs co-led by 2 mental health clinicians who follow a protocol that includes predetermined agendas that structure the outline of each group. The group leaders are trained to elicit and address the specific concerns of each CG during each session. The content of each group is determined by the CGs based on an initial go-round check-in to elicit current caregiving problems and challenges, emotional reactions and foster group cohesion. In sessions 1-4, CGs are formally taught a form of problem-solving therapy (PST) adapted for dementia CGs. Sessions 5-8 utilize simulation to train CGs to effectively communicate with the person they are caring for and learn how to engage with them to manage dementia induced behaviours such as resistance or demandingness. Communication training is done with live therapeutic simulation a hands-on training method that employs specially trained standardized patients (SP) in a tightly controlled intervention developed for the CARERS program. All group leaders were trained in a standardized training protocol at the Reitman Centre. CGs completed self-administered questionnaires at entry to the study, just prior to starting the first group and, immediately after session 8 of the group therapy. Care recipient (CR)function and demographic and socioeconomic information was gathered for each CG/CR at entry into the study. Statistical analysis employed IBM SPSS 26 and univariate general linear model (UNIANOVA) analysis and parametric tests.

Study Type

Interventional

Enrollment (Actual)

264

Phase

  • Not Applicable

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Locations

    • Ontario
      • Toronto, Ontario, Canada, M5p3c3
        • Joel Sadavoy

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

18 years and older (ADULT, OLDER_ADULT)

Accepts Healthy Volunteers

Yes

Genders Eligible for Study

All

Description

Inclusion Criteria:

  • adult, informal caregiver (CG) of a person with diagnosis of dementia who resided in the community; sufficient emotional and physical capacity to participate in the assessment and training sessions; no active suicidality or psychotic illness; willing to discontinue other CG intervention programs while in the study; and provided signed consent for the study.

Exclusion Criteria:

  • insufficient emotional and physical capacity to participate in the assessment and training sessions; active suicidality or psychotic illness; unwilling to discontinue other CG intervention programs while in the study

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

  • Primary Purpose: TREATMENT
  • Allocation: NON_RANDOMIZED
  • Interventional Model: SINGLE_GROUP
  • Masking: NONE

Arms and Interventions

Participant Group / Arm
Intervention / Treatment
Experimental: Carers group intervention
caregivers entered into the 8 week CARERS intervention (N=264) Group intervention, 8 x 2 hour sessions. Session 1-4 PST training, session 5-8 Simulation with standardized patients training Pre- post evaluations completed
As described above
No Intervention: Wating list control
Caregivers waiting for entry into active arm of CARERS intervention.During this time usual care allowed with no other intervention. Study measures administered at intake and immediately prior to starting the CARERS group. (N=83)

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Center for Epidemiologic Studies Depression Scale- CESD) Eaton et al., 1977
Time Frame: Change in depression score from baseline at 8 weeks
standardized diagnostic measure of depression
Change in depression score from baseline at 8 weeks
perceived stress scale - PSS Cohen, S et al., 1983
Time Frame: Change in stress score from baseline at 8 weeks
self assessment standardized measure of self perceived stress
Change in stress score from baseline at 8 weeks
Mastery (Pearlin et al., 1990)
Time Frame: Change in mastery score from baseline 8 weeks
self assessment standardized measure of perceived sense of mastery in caregiving
Change in mastery score from baseline 8 weeks
caregiving competence(Pearlin et al., 1990)
Time Frame: Change in caregiving competence score from baseline at 8 weeks
Self assessment standardized measure of key areas of perceived competence in caregiving
Change in caregiving competence score from baseline at 8 weeks
role captivity (Pearlin et al., 1990)
Time Frame: Change in role captivity score from baseline at 8 weeks
Self administered standardized measure of degree of perceived entrapment in the caregiving role
Change in role captivity score from baseline at 8 weeks
role overload(Pearlin et al., 1990)
Time Frame: Change in role overload score from baseline at 8 weeks
self administered standardized measure of degree of experienced caregiving overload
Change in role overload score from baseline at 8 weeks
Short Zarit Burden Inventory- SZBI), (Bedard et al., 2001)
Time Frame: Change in burden score from baseline at 8 weeks
Self administered Standardized measure of burden of caregiving
Change in burden score from baseline at 8 weeks
coping (Endler and Parker 1990)
Time Frame: Change from Baseline at 8 weeks
Self administered scale of caregiver's perception of coping
Change from Baseline at 8 weeks
coping (Endler & Parker, 1990)
Time Frame: Change in coping from baseline at 8 weeks
Self administered scale of caregivers perception of coping
Change in coping from baseline at 8 weeks

Secondary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Caregiver demographics
Time Frame: through study completion on average about 4 months
general demographic profile
through study completion on average about 4 months
Katz Index of Independence in Activities of Daily Living (Katz ADL) (Katz, Downs, Cash, & Grotz, 1970)
Time Frame: change from Baseline at 8 weeks
Measure of care recipient daily function as observed by caregiver
change from Baseline at 8 weeks
Lawton Instrumental Activities of Daily Living Scale (Lawton ADL) (Lawton & Brody, 1969)
Time Frame: Change from Baseline at 8 weeks
measure of care recipients daily instrumental activities of daily living as observed by the caregiver
Change from Baseline at 8 weeks
Revised Memory and Behaviour Checklist- RMBPC) (Teri et al., 1992)
Time Frame: Baseline and after completion of the 8 week intervention
Caregiver's reaction to CR's memory and behavioural symptoms (completed by caregiver)
Baseline and after completion of the 8 week intervention

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Investigators

  • Principal Investigator: Joel Sadavoy, Mount Sinai Hospital

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start (Actual)

January 1, 2013

Primary Completion (Actual)

September 30, 2017

Study Completion (Actual)

December 31, 2017

Study Registration Dates

First Submitted

July 21, 2020

First Submitted That Met QC Criteria

July 24, 2020

First Posted (Actual)

July 28, 2020

Study Record Updates

Last Update Posted (Actual)

July 29, 2020

Last Update Submitted That Met QC Criteria

July 27, 2020

Last Verified

July 1, 2020

More Information

Terms related to this study

Plan for Individual participant data (IPD)

Plan to Share Individual Participant Data (IPD)?

NO

Drug and device information, study documents

Studies a U.S. FDA-regulated drug product

No

Studies a U.S. FDA-regulated device product

No

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Clinical Trials on Carer Stress Syndrome

Clinical Trials on Group psychotherapy

Subscribe